Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Diltiazem hydrochloride
Cephalon UK Limited
C08DB; C08DB01
Diltiazem hydrochloride
120 milligram(s)
Prolonged-release capsule
Product subject to prescription which may be renewed (B)
Benzothiazepine derivatives; diltiazem
Marketed
1990-07-04
PACKAGE LEAFLET: INFORMATION FOR THE USER DILZEM XL 120 MG, 180 MG, 240 MG PROLONGED-RELEASE HARD CAPSULES (diltiazem hydrochloride) READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET: 1. WHAT DILZEM XL IS AND WHAT IT IS USED FOR 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE DILZEM XL 3. HOW TO TAKE DILZEM XL 4. POSSIBLE SIDE EFFECTS 5. HOW TO STORE DILZEM XL 6. CONTENTS OF THE PACK AND OTHER INFORMATION 1. WHAT DILZEM XL IS AND WHAT IT IS USED FOR DILZEM XL contains the active ingredient, diltiazem hydrochloride. Diltiazem belongs to a group of medicines called calcium channel blockers. These medicines work to lower blood pressure and ease anginal chest pain by preventing the narrowing of blood vessels. DILZEM XL is used to treat and control MILD TO MODERATELY HIGH BLOOD PRESSURE and to prevent and treat CHEST PAIN due to the narrowing of blood vessels in the heart. DILZEM XL is designed to release the active ingredient, diltiazem, in a controlled manner throughout the whole day so that blood pressure and angina are treated for a full 24 hour period. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE DILZEM XL DO NOT TAKE DILZEM XL IF YOU: - are allergic to diltiazem hydrochloride or any of the other ingredients of this medicine (see section 6) - are a woman of a child-bearing potential and are not using contraception (see “Pregnancy, breast-feeding and fertility”) - are pregnant, think you may be pregnant or are breast-feeding (see “Pregnancy, breast- feeding and fertility”) - are currently in shock (reduced bl Read the complete document
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Dilzem XL 120mg Prolonged-release hard capsules. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each Dilzem XL 120mg capsule contains diltiazem hydrochloride 120mg. Excipients with known effect: Each capsule contains 25.2mg sucrose For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Prolonged-release capsule, hard. White, hard gelatin capsules, printed with ‘e120’ and containing roughly spherical white to off-white beads. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Dilzem XL is indicated in adults for: prophylaxis and treatment of angina pectoris; treatment of mild to moderate hypertension. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology _ADULTS:_ _Hypertension:_ The usual initial dose is one 180mg capsule per day (corresponding to 180 mg of diltiazem hydrochloride once daily). Depending upon the clinical response the patient’s dosage may be increased stepwise to 360mg/day if required. _Angina Pectoris:_ The usual initial dose is one 180mg capsule per day (corresponding to 180mg of diltiazem hydrochloride once daily). Depending on the clinical response the patient’s dosage may be increased stepwise to 360mg/day if required. _ELDERLY:_ Dosage should commence at the lower level of 120mg once-daily and be increased slowly. Do not increase the dose if the heart rate falls below 50 beats per minute. _PATIENTS WITH HEPATIC IMPAIRMENT:_ Dosage should commence at the lower level of 60 mg twice daily and be increased slowly. Do not increase the dose if the heart rate falls below 50 beats per minute. See section 4.4. _PATIENTS WITH RENAL IMPAIRMENT:_ Dosage should commence at the lower level of 60 mg twice daily and be increased slowly. Do not increase the dose if the heart rate falls below 50 beats per minute. See section 4.4. _PAEDIATRIC POPULATION:_ This product is not recommended for use in children. H E A L T H P R O D U C T S R E G U L A T O R Y A U T H O R I T Y ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ Read the complete document